Nathalie Dubois-Stringfellow, Ph.D, is currently Vice President, Product Development and Management at Sangamo BioSciences. She joined Sangamo in January 2011 as Sr Director Product Development and Management overseeing multiple project teams of gene and cell therapy products for hemophilia, Huntington disease, Hemoglobinopathies, HIV and Lysosomal diseases. Prior to joining Sangamo, she has held various positions implementing and managing preclinical and clinical development programs of Biologics in the field of oncology, as well as immune, infectious and genetic diseases. During her career, Nathalie has worked in Discovery Research, Preclinical Research, Project Management, Clinical Development, and Portfolio Management at Chiron, Bayer, Signature Biosciences, XOMA and Sangamo BioSciences. Dr Dubois-Stringfellow received her Ph.D. in Human Genetics from the Université Pierre et Marie Curie in Paris, France.